• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 MARATHON; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 MARATHON; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number UNK-NV-MARATHON
Device Problem Difficult to Remove (1528)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 07/01/2008
Event Type  Injury  
Manufacturer Narrative
B3: date is approximate.Month and year are confirmed valid.Concomitant medical products: product id unk-nv-onyx.G2: citation: authors: walcott b, gerrard j, nogueira r, nahed b, terry a, ogilvy c.Microsurgical retrieval of an endovascular microcatheter trapped during onyx embolization of a cerebral arteriovenous malformation.J neurointervent surg 3:77e79 2011.10.1136/j nis.2010.002733.Earliest date of publication used for date of event no unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Cerebral arteriovenous malformations (avms) are vascular lesions that are amenable to various treatment modalities including stereotactic radiosurgery, fractionated radiotherapy, endovascular embolization, microsurgical obliteration or combined modality treatment.A potential complication of endovascular therapy with embolization material is microcatheter entrapment.We report on a patient for whom surgery was combined with endovascular embolization to obliterate an avm and retrieve an entrapped endovascular microcatheter.A 52-year-old woman suffered a left parietal hemorrhage from an avm.She underwent staged endovascular embolization of the lesion using onyx material.During the second stage of the embolization, the microcatheter was retained in the onyx plug.It was decided to section the microcatheter at the groin and proceed with microsurgical obliteration of the avm, with removal of the entrapped microcatheter remnant.The avm was dissected circumferentially allowing the meticulous obliteration of the feeding vessels.A single remaining feeding vessel originating from the distal anterior cerebral artery was identified and suspected to contain the entrapped microcatheter.The location was confirmed using stereotactic guidance and the vessel was then sectioned allowing complete removal of the avm.The microcatheter (102 cm) was then extracted cranially using gentle traction.This demonstrates the first incidence of microcatheter removal after procedural entrapment in onyx embolization material.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MARATHON
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key17641796
MDR Text Key322168196
Report Number2029214-2023-01513
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNK-NV-MARATHON
Device Catalogue NumberUNK-NV-MARATHON
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/31/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10...
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient SexFemale
-
-